Search results for " Elimi"

showing 10 items of 91 documents

Synthesis of 3-alkyl-4-(cholomethyl)-1-RSO2-1-H-pyrrol-2-(5H)ones, using a sequential ATCR/[1,2] elimination, from 2,2-dichloro-N-(2-chloroallyl)-N-R…

2011

copper cyclization elimination lactams radical reactionSettore CHIM/06 - Chimica Organica
researchProduct

The Application of Supercritical Fluids Technology to Recover Healthy Valuable Compounds from Marine and Agricultural Food Processing By-Products: A …

2021

Food by-products contain a remarkable source of bioactive molecules with many benefits for humans; therefore, their exploitation can be an excellent opportunity for the food sector. Moreover, the revalorization of these by-products to produce value-added compounds is considered pivotal for sustainable growth based on a circular economy. Traditional extraction technologies have several drawbacks mainly related to the consumption of hazardous organic solvents, and the high temperatures maintained for long extraction periods which cause the degradation of thermolabile compounds as well as a low extraction efficiency of desired compounds. In this context, supercritical fluid extraction (SFE) ha…

green extractionBioengineeringContext (language use)02 engineering and technologylcsh:Chemical technology7. Clean energy12. Responsible consumptionlcsh:Chemistry0404 agricultural biotechnologyHazardous wastehealth effectsChemical Engineering (miscellaneous)active compoundslcsh:TP1-11852. Zero hungerbusiness.industryProcess Chemistry and TechnologyCircular economyExtraction (chemistry)Supercritical fluid extraction04 agricultural and veterinary sciences021001 nanoscience & nanotechnology040401 food scienceSupercritical fluid3308.07 Eliminación de Residuoslcsh:QD1-99913. Climate actionAgricultureFood processingEnvironmental scienceBiochemical engineeringsupercritical fluid extraction0210 nano-technologybusinessagro-industrial by-products3303.03 Procesos Químicos3302.90 Ingeniería BioquímicaProcesses
researchProduct

Investigation about selective harmonic elimination in unbalanced multilevel inverters

2022

In this paper 5 and 7 levels cascaded H-bridges inverters are considered, feeding by unequal dc voltage sources. The effect of these unbalancing operation is examined concerning harmonic analysis and total harmonic distortion of the output voltages. The system of equations, obtained by the expansion in the Fourier series of phase output voltage, is solved by applying a method of graphic solution that allows obtaining the switching angles able to eliminate the lower order harmonics.

l-level Cascaded H-bridges (CHB) InvertersPower QualityTotal Harmonic Distortion (THD)Power Quality; Selective Harmonic Elimination (SHE); Total Harmonic Distortion (THD); l-level Cascaded H-bridges (CHB) Invertersl-level Cascaded H-bridges (CHB) InverterSelective Harmonic Elimination (SHE)
researchProduct

Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements

2021

The World Health Organization (WHO) targets for eliminating HCV by 2030 may be overambitious for many high-income countries. Recent analyses (ie, data from 2017 to 2019) show that only 11 countries are on track for meeting WHO’s elimination targets. For a country to be truly on track, it is important that the majority of infected individuals be identified and treated. There is still a need for country and population-specific evaluations within the different HCV screening and treatment strategies available, in order to assess their cost-effectiveness and sustainability and support an evidence-based policy for HCV elimination. Any health policy model is affected by the diversity and quality o…

media_common.quotation_subjectWorld Health Organizationdisease burden03 medical and health sciences0302 clinical medicineOrder (exchange)PandemicHumansQuality (business)Disease EradicationSet (psychology)Disease burdenHealth policymedia_commonPublic economicsHepatologyHCV screeningHealth PolicymicroeliminationCOVID-19Hepatitis CWHO targetHCV elimination030220 oncology & carcinogenesisSustainability030211 gastroenterology & hepatologyBusinessHumanDiversity (politics)Liver International
researchProduct

Is elimination of HCV in 2030 realistic in Central Europe.

2021

According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV e…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Hepatitis C virusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.disease_causeAntiviral Agents03 medical and health sciences0302 clinical medicineEpidemiologymedicinePrevalenceHumansHepatologybusiness.industrySARS-CoV-2virus diseasesCOVID-19Hepatitis Cmedicine.diseaseVirologyHepatitis Cdigestive system diseasesHcv eliminationEuropeRegimen030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessLiver international : official journal of the International Association for the Study of the LiverREFERENCES
researchProduct

Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH)

2019

La Asociación Española para el Estudio del Hígado (AEEH) está convencida de que la eliminación de la hepatitis C en España es posible siempre y cuando seamos capaces de emplear los recursos y las herramientas necesarias para la misma. Este documento refleja la posición de la AEEH respecto a la eliminación del virus de la hepatitis C (VHC), estableciendo una amplia serie de recomendaciones que se pueden agrupar en cinco categorías: 1) cribado del VHC en función de la edad, de la existencia de factores de riesgo clásicos de adquisición de la infección, búsqueda activa de pacientes diagnosticados con anterioridad y desarrollo de estrategias de microeliminación en poblaciones vulnerables; 2) si…

medicine.medical_specialtyHepatologybusiness.industryHepatitis C virusGastroenterologyHepatitis Cmedicine.diseasemedicine.disease_causePatient careHcv elimination03 medical and health sciences0302 clinical medicinemedicine030211 gastroenterology & hepatologyPatient treatment030212 general & internal medicineIntensive care medicinebusinessHealth policy
researchProduct

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal

2021

Abstract Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has set a goal to eliminate HCV by 2030. Despite the availability of direct‐acting antivirals—highly effective and well‐tolerated therapies for HCV—many patients infected with HCV in Germany have not initiated treatment, including a majority of those who are aware of their positive diagnosis. Barriers to screening, diagnosis, and treatment are major factors taking many countries off track for HCV elimination by 2030. Identifying country‐specific barriers and challenges, particularly in at‐risk populations such as people who injec…

medicine.medical_specialtybusiness.industryHepatitis C virusbarriersRReviewsvirus diseasesReviewGeneral MedicineHepatitis Chigh‐risk groupsmedicine.diseasemedicine.disease_causeHepatitis CHcv eliminationWorld healthdigestive system diseasesMen who have sex with meneliminationFamily medicineGermanyMedicineMedicinebusinessGood practiceHealth Science Reports
researchProduct

Reactions of m-Terphenyl-Stabilized Germylene and Stannylene with Water and Methanol: Oxidative Addition versus Arene Elimination and Different React…

2015

Reactions of the divalent germylene Ge(ArMe6)2 (ArMe6 = C6H3-2,6-{C6H2-2,4,6-(CH3)3}2) with water or methanol gave the Ge(IV) insertion product (ArMe6)2Ge(H)OH (1) or (ArMe6)2Ge(H)OMe (2), respectively. In contrast, its stannylene congener Sn(ArMe6)2 reacted with water or methanol to produce the Sn(II) species {ArMe6Sn(μ-OH)}2 (3) or {ArMe6Sn(μ-OMe)}2 (4), respectively, with elimination of ArMe6H. Compounds 1–4 were characterized by IR and NMR spectroscopy as well as by X-ray crystallography. Density functional theory calculations yielded mechanistic insight into the formation of (ArMe6)2Ge(H)OH and {ArMe6Sn(μ-OH)}2. The insertion of an m-terphenyl-stabilized germylene into the O–H bond was…

oxidative additionMetathesisPhotochemistryDFT calculationsMedicinal chemistryReductive eliminationInorganic Chemistrychemistry.chemical_compoundTerphenylreaktiomekanismiReactivity (chemistry)metallylenesarene eliminationPhysical and Theoretical Chemistryta116Chemistryareenin eliminaatioArylOrganic ChemistryNuclear magnetic resonance spectroscopyOxidative additionmetallyleenitDFT laskutMethanolreaction mechanismhapettava additioOrganometallics
researchProduct

Controlling Oxidative Addition and Reductive Elimination at Tin(I) via Hemi-Lability.

2021

We report on the synthesis of a distannyne supported by a pincer ligand bearing pendant amine donors that is capable of reversibly activating E–H bonds at one or both of the tin centres through dissociation of the hemi-labile N–Sn donor/acceptor interactions. This chemistry can be exploited to sequentially (and reversibly) assemble mixed-valence chains of tin atoms of the type ArSn{Sn(Ar)H} n SnAr ( n = 1, 2). The experimentally observed (decreasing) propensity towards chain growth with increasing chain length can be rationalized both thermodynamically and kinetically by the electron-withdrawing properties of the –Sn(Ar)H– backbone units generated via oxidative addition. peerReviewed

oxidative additionchemistry.chemical_element010402 general chemistry01 natural sciencesCatalysisDissociation (chemistry)Reductive eliminationreversibilityNucleophilic aromatic substitutiontinPolymer chemistryPincer ligandkemiallinen synteesiChemistry010405 organic chemistryreductive eliminationliganditkompleksiyhdisteetGeneral ChemistryGeneral MedicineAcceptorOxidative addition3. Good health0104 chemical scienceshemi-labile ligandorgaaniset tinayhdisteettinaAmine gas treatingTinAngewandte Chemie (International ed. in English)
researchProduct

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experi…

2022

HCV elimination; Mental health disorders; Sofosbuvir/velpatasvir Eliminación del VHC; Trastornos de salud mental; Sofosbuvir/velpatasvir Eliminació del VHC; Trastorns de salut mental; Sofosbuvir/velpatasvir Hepatitis C virus (HCV) is prevalent in people with mental health disorders, a priority population to diagnose and cure in order to achieve HCV elimination. This integrated analysis pooled data from 20 cohorts in seven countries to evaluate the real-world effectiveness of the pangenotypic direct-acting antiviral (DAA) sofosbuvir/velpatasvir (SOF/VEL) in people with mental health disorders. HCV-infected patients diagnosed with mental health disorders who were treated with SOF/VEL for 12 w…

real-worldGenotype:Mental Disorders [PSYCHIATRY AND PSYCHOLOGY]:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Hepacivirus:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Antiviral AgentsMental health disordersVirologyMedicaments antivírics - Ús terapèuticHumans:Other subheadings::/therapeutic use [Other subheadings]sofosbuvir/velpatasvir:trastornos mentales [PSIQUIATRÍA Y PSICOLOGÍA]:Otros calificadores::/uso terapéutico [Otros calificadores]Mental Disorders:virosis::hepatitis viral humana::hepatitis C [ENFERMEDADES]:Virus Diseases::Hepatitis Viral Human::Hepatitis C [DISEASES]HCV elimination; HCV; mental health disorders; real-world; sofosbuvir/velpatasvirHepatitis C:Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents [CHEMICALS AND DRUGS]Infectious DiseasesReal-worldSofosbuvir/velpatasvirHCV elimination:acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antivíricos [COMPUESTOS QUÍMICOS Y DROGAS]HCVmental health disordersSofosbuvirMalalties mentalsHepatitis C - TractamentViruses
researchProduct